Floris H P van Velden
Overview
Explore the profile of Floris H P van Velden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
2580
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van de Burgt A, van Velden F, Kwakkenbos K, Smit F, de Geus-Oei L, Dekkers I
Med Phys
. 2024 May;
51(6):4069-4080.
PMID: 38709908
Purpose: Assessing renal perfusion in-vivo is challenging and quantitative information regarding renal hemodynamics is hardly incorporated in medical decision-making while abnormal renal hemodynamics might play a crucial role in the...
12.
Hendriks P, Rietbergen D, van Erkel A, Coenraad M, Arntz M, Bennink R, et al.
Eur J Nucl Med Mol Imaging
. 2024 Feb;
51(7):2085-2097.
PMID: 38329507
Purpose: The aim of this study was to investigate the biodistribution of (super-)selective trans-arterial radioembolization (TARE) with holmium-166 microspheres (Ho-MS), when administered as adjuvant therapy after RFA of HCC 2-5...
13.
Noortman W, Aide N, Vriens D, Arkes L, Slump C, Boellaard R, et al.
Cancers (Basel)
. 2023 Jun;
15(10).
PMID: 37345017
Aim: To build and externally validate an [F]FDG PET radiomic model to predict overall survival in patients with head and neck squamous cell carcinoma (HNSCC). Methods: Two multicentre datasets of...
14.
Pullen L, Noortman W, Triemstra L, de Jongh C, Rademaker F, Spijkerman R, et al.
Cancers (Basel)
. 2023 Jun;
15(11).
PMID: 37296837
Aim: To improve identification of peritoneal and distant metastases in locally advanced gastric cancer using [F]FDG-PET radiomics. Methods: [F]FDG-PET scans of 206 patients acquired in 16 different Dutch hospitals in...
15.
de Vries B, Zwezerijnen G, Burchell G, van Velden F, Menke-van der Houven van Oordt C, Boellaard R
Front Med (Lausanne)
. 2023 May;
10:1180773.
PMID: 37250654
Rational: Deep learning (DL) has demonstrated a remarkable performance in diagnostic imaging for various diseases and modalities and therefore has a high potential to be used as a clinical tool....
16.
Vuijk F, Feshtali Shahbazi S, Noortman W, van Velden F, Dibbets-Schneider P, Marinelli A, et al.
Nucl Med Commun
. 2023 May;
44(7):613-621.
PMID: 37132268
Objective: In this pilot study, we investigated the feasibility of response prediction using digital [ 18 F]FDG PET/computed tomography (CT) and multiparametric MRI before, during, and after neoadjuvant chemoradiation therapy...
17.
Chen L, van de Burgt A, Smit F, Audhoe R, de Boer S, van Velden F, et al.
Nucl Med Commun
. 2023 Mar;
44(6):495-501.
PMID: 36951877
Objective: Since the end of 2019, the coronavirus disease 2019 (COVID-19) virus has infected millions of people, of whom a significant group suffers from sequelae from COVID-19, termed long COVID....
18.
Straat M, Hoekx C, van Velden F, Arias-Bouda L, Dumont L, Blondin D, et al.
Cell Rep Med
. 2023 Feb;
4(2):100942.
PMID: 36812890
While brown adipose tissue (BAT) is activated by the beta-3-adrenergic receptor (ADRB3) in rodents, in human brown adipocytes, the ADRB2 is dominantly present and responsible for noradrenergic activation. Therefore, we...
19.
Dotinga M, Vriens D, van Velden F, Stam M, Heemskerk J, Dibbets-Schneider P, et al.
Diagnostics (Basel)
. 2022 Dec;
12(12).
PMID: 36553163
: Management of patients with radioiodine (RAI)-refractory differentiated thyroid cancer (DTC) is a challenge as I-131 therapy is deemed ineffective while standard-of-care systemic therapy with tyrosine kinase inhibitor (TKI) lenvatinib...
20.
Vuijk F, Kleiburg F, Noortman W, Heijmen L, Feshtali Shahbazi S, van Velden F, et al.
Cancers (Basel)
. 2022 Dec;
14(24).
PMID: 36551695
Current imaging modalities frequently misjudge disease stage in colorectal, gastric and pancreatic cancer. As treatment decisions are dependent on disease stage, incorrect staging has serious consequences. Previous preclinical research and...